Wasa here's a couple of clues/insights into current share price:
- they have an unproven business model, whilst it sounds good in theory there is no one else really around the world that you can point to that are doing the same thing and showing any great deal of success.
- nobody likes a business that needs to raise funds repeatedly and does so at a lower price than before, it creates trapped investors and a vicious circle, it's not looking likely at all that they'll be raising above 10 cents anytime soon, and the quarterly should show they are eating through their cash quick.
- management can do more to communicate their plan
The current market is at or near 10X their most recently announced annualised revenue run rate, so I wouldn't really say it's undervalued, it's definitely not pricing in blue sky but still has a lot of 'growth' built in if you compare to similar stage techs.
- Forums
- ASX - By Stock
- CSK
- As a non-holder (thus far), I have an
As a non-holder (thus far), I have an, page-7
Featured News
Add CSK (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online